Mycophenolate mofetil Recruiting Phase 3 Trials for Glomerulonephritis, Membranous Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01282073Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy